Back to Search
Start Over
Supplementary Table 1 from A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Table 1 - PDF file 54K, Number (percentage) of patients exhibiting increased ventricular ectopic activity
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3bc3771585f876d8b010770be7fcfcb2
- Full Text :
- https://doi.org/10.1158/1078-0432.22449671